NYSE: PFE

Explore the latest insights on NYSE: PFE and its impact on China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data, news, and intelligence to help you navigate the complexities of NYSE: PFE’s developments with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

CSPC Initiates Phase Ib Trial of JMT206 – First‑in‑Human Dual ActR‑IIA/IIB Monoclonal Antibody Targeting Weight Management with Muscle Preservation
CompanyDrug

CSPC Initiates Phase Ib Trial of JMT206 – First‑in‑Human Dual ActR‑IIA/IIB Monoclonal Antibody Targeting Weight Management with Muscle Preservation

CSPC Pharmaceutical Group Limited (HKG: 1093) announced that the Phase Ib clinical trial of its self‑developed drug JMT206, for weight management in adult patients who are overweight or obese, has…

Jiangsu Nhwa Signs Exclusive Global Licensing Deal with Somnivera – Clinical‑Stage Sleep‑Disorder Asset Backed by Up to US$517.5 Million in Potential Value

Jiangsu Nhwa Signs Exclusive Global Licensing Deal with Somnivera – Clinical‑Stage Sleep‑Disorder Asset Backed by Up to US$517.5 Million in Potential Value

MindRank Signs Exclusive Greater China Commercialization Deal With Sunshine Mandi for MDR‑001 – AI‑Designed Oral GLP‑1 Candidate in Phase III for Obesity, Worth Up to RMB 1.75 Billion

MindRank Signs Exclusive Greater China Commercialization Deal With Sunshine Mandi for MDR‑001 – AI‑Designed Oral GLP‑1 Candidate in Phase III for Obesity, Worth Up to RMB 1.75 Billion

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDeals

Pfizer Partners with CSPC Pharmaceutical to Localize Paxlovid in China

CompanyDrug

Pfizer’s Prevenar 13 Receives Expanded Age Range Approval in China

CompanyDeals

Pfizer and Sinopharm Expand Partnership to Enhance Drug Distribution and Lifecycle Solutions

CompanyDrug

Pfizer’s Ritlecitinib Heads for Priority Review in China for Vitiligo Treatment

CompanyDeals

Pfizer Partners with HCRC to Support ‘Healthy China’ Initiative

CompanyDrug

AIM Vaccine Initiates Phase I Clinical Study for MCV4 Meningococcal Vaccine in China

Company

Pfizer Reports Record Revenues as COVID-19 Sales Soar; 2023 Guidance Amid Market Shifts

CompanyDrug

Pfizer’s Nurtec ODT Launches in China via Hainan’s Bo’Ao Lecheng Zone

Show More